Tenet Healthcare (THC) Tops Q2 EPS by 114c; offers guidance

Tenet Healthcare (NYSE: THC) reported Q2 EPS of $4.02, $1.14 better than the analyst estimate of $2.88. Revenue for the quarter came in at $5.27 billion versus the consensus estimate of $5.16 billion.

GUIDANCE:

Tenet Healthcare sees FY2025 EPS of $15.55-$16.21, versus the consensus of $12.83. Tenet Healthcare sees FY2025 revenue of $20.95-21.25 million, versus the consensus of $20.92 million.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
• Anbio Biotechnology (NNNN) has filed mixed shelf
• ImmuCell reports 11.5% sales rise in Q2 2026, 20.9% gain for first half